Review of clinical trial data on Ozempic and hair loss Clinical data shows that about 0.80% of patients reported telogen effluvium or non-scarring hair loss within six months after starting Semaglutide at 0.25-2mg weekly doses [7]
Taking the medication early does not necessarily speed up weight loss and is not recommended as a weight-loss tactic. The goal of early dosing should be lifestyle flexibility, not increasing the rate of fat loss
These medications also have potential serious side effects, like pancreatitis, gallbladder issues, and thyroid tumors, so any history of these conditions is a direct contraindication for prescribing, says Dr
A comparative study with census of the basal melanocyte population
Last Published 05.01.2026 Effective Date: 05.01.2026 This policy addresses the use of Qalsody (tofersen) for the treatment of amyotrophic lateral sclerosis (ALS)
doi:10.1172/jci.insight.140532 28